Blastomycosis in Dogs: Symptoms, Diagnosis, and Treatment

Blastomycosis is a serious fungal infection that affects dogs across various regions of the United States and beyond. This disease is caused by the fungus Blastomyces dermatitidis, which is found in soil and decaying organic matter, particularly in moist environments near water sources. Understanding this condition is crucial for dog owners, as early detection and treatment can significantly improve outcomes. This guide provides comprehensive information about blastomycosis in dogs, including its causes, clinical signs, diagnostic procedures, treatment options, and prognosis.

What is Blastomycosis?

Blastomycosis is an infectious fungal disease that primarily affects the lungs but can spread to other body systems including the skin, bones, urinary tract, eyes, and central nervous system. Dogs contract blastomycosis by inhaling spores of Blastomyces dermatitidis from contaminated soil and organic debris. The infection develops when these spores are inhaled and begin to germinate in the warm environment of the dog’s lungs, where they convert to a parasitic form capable of causing disease.

The geographic distribution of blastomycosis is associated with specific environmental conditions. The fungus thrives in warm, moist soil, particularly in regions near rivers, streams, lakes, and other water sources. Dogs that spend significant time outdoors digging in soil or exploring wooded areas are at higher risk of exposure. While blastomycosis can occur in dogs throughout North America, it is more prevalent in certain regions, particularly around the Mississippi, Ohio, and Saint Lawrence River valleys.

Clinical Signs and Symptoms

The symptoms of blastomycosis in dogs vary depending on which organ systems are affected by the infection. Most dogs develop respiratory signs initially, as the fungus primarily infects the lungs. However, clinical presentation can be quite variable, and symptoms may develop gradually or appear suddenly in some cases.

Respiratory Symptoms

Respiratory involvement occurs in 65% to 85% of infected dogs. Common respiratory signs include:

• Persistent cough that may be dry or productive
• Difficulty breathing or shortness of breath
• Exercise intolerance or reluctance to engage in physical activity
• Rapid breathing (tachypnea)
• Labored breathing or respiratory distress
• Blue-tinged gums or tongue (cyanosis) in severe cases

Systemic and General Symptoms

Beyond respiratory signs, infected dogs often exhibit nonspecific signs of illness. These general symptoms include fever (temperature above 103°F or 39.4°C), which is present in 40% to 60% of infected dogs, weight loss, poor appetite or anorexia, and lethargy. These systemic signs may be the first indicators that prompt owners to seek veterinary care.

Skin and Lymph Node Involvement

In some dogs, blastomycosis affects the skin, causing various lesions. These skin manifestations may include pustules or pimple-like bumps, rash-like lesions, and occasionally draining nodules with open tracts. Lymph node enlargement (lymphadenopathy) is another common finding, particularly in the lymph nodes draining the respiratory tract.

Other Organ System Involvement

When the infection spreads beyond the lungs, dogs may develop symptoms related to other affected organs. These can include urinary issues such as difficulty urinating, bloody urine, or enlarged testicles in males; eye problems including inflammation, swelling, or vision loss; lameness or limping from bone involvement; and neurological signs such as head tilts or seizures if the central nervous system is affected.

Diagnosis of Blastomycosis

Accurate diagnosis is essential for initiating appropriate treatment promptly. Veterinarians typically suspect blastomycosis when a dog presents with a combination of clinical signs including lethargy, fever, weight loss, and lymph node enlargement, particularly if the dog has had exposure to environments where the fungus is known to exist.

Diagnostic Methods

Several diagnostic techniques can confirm blastomycosis. Thoracic radiography (chest X-rays) is highly recommended for all dogs suspected of having the disease. These radiographs may reveal characteristic lung lesions and changes that suggest fungal infection. Some lung lesions may be clinically silent, making radiographic examination crucial even when respiratory symptoms are not apparent.

Laboratory testing is another important diagnostic tool. Antigen testing can detect fungal antigens in blood serum, urine, or other body fluids. This test is highly specific for blastomycosis and can provide rapid confirmation of the diagnosis. Cytology or histopathology of affected tissues may also reveal the characteristic fungal organisms, allowing for microscopic identification.

Additionally, fungal culture from respiratory secretions or tissue samples can be performed, though this method typically takes longer than other diagnostic approaches. Serologic testing to detect antibodies against the fungus may also be employed in some cases.

Treatment Options for Blastomycosis

Yes, blastomycosis can be treated, although not all affected pets will survive. Fortunately, newer antifungal agents are well tolerated by most dogs and have relatively few side effects compared to medications used previously.

Primary Treatment: Itraconazole

Itraconazole is the preferred drug of treatment for most dogs with blastomycosis. This antifungal medication is administered orally at a dose of 5 mg/kg every 24 hours. Itraconazole should be given with food to enhance absorption. A minimum of three months of continuous treatment is necessary, and therapy should be continued until active disease is not apparent. In most cases, dogs require several months of therapy—at least four to six months in most cases—to successfully treat this disease. Clinical cure can be expected in approximately 70% of dogs treated with itraconazole, though recurrence may occur months or years after treatment in about 20% of treated dogs.

Itraconazole is favored because it has fewer side effects than other medications and is generally well-tolerated by dogs. Blood levels should be monitored approximately two weeks after starting treatment to ensure therapeutic drug concentrations are achieved.

Alternative Antifungal Medications

Several other antifungal drugs are available for treating blastomycosis if itraconazole cannot be used or if the dog does not respond adequately to initial therapy. These include:

• Fluconazole – An azole antifungal with relatively good tolerability
• Ketoconazole – Another azole option, though generally less preferred than itraconazole
• Voriconazole – A newer azole antifungal agent
• Terbinafine – A different class of antifungal, though typically not combined with itraconazole
• Amphotericin B – A potent antifungal reserved for severe cases

Amphotericin B for Severe Cases

Amphotericin B may be administered during initial treatment of dogs with severe or rapidly progressive blastomycosis to improve the rate of recovery. In life-threatening cases, amphotericin B is often recommended as a first course of treatment, though it has numerous side effects including potential kidney damage (nephrotoxicity). Dogs may be given steroids during the first weeks of treatment to decrease inflammation, particularly if respiratory symptoms worsen.

In fulminating cases of blastomycosis, especially those with evidence of oxygen deprivation, combination treatment with amphotericin B and itraconazole is recommended. When drugs are used in combination, they are administered simultaneously initially, and then itraconazole is continued as a sole agent once the desired cumulative dose of amphotericin B has been administered. Combination therapy allows for a decreased total dose of amphotericin B to be administered, potentially reducing the risk of nephrotoxicity.

Supporting Care

Dogs with difficulty breathing may require oxygen therapy and hospitalization until they improve. In severe cases, or when medication does not work as expected, prolonged hospital stays, intravenous medications, and further supportive care may be necessary. Dogs whose eyes are severely affected may require topical medications or, in significantly affected cases, surgical removal of the eye.

Treatment Duration and Response to Therapy

Treatment duration is a critical aspect of blastomycosis management. Dogs should be administered itraconazole or other azole antifungals for at least 60 days in all infected dogs, and treatment should continue for at least one month after all clinical and radiographic evidence of disease has resolved. Dogs with severe lung involvement should be treated for at least 90 days. The first week or two of treatment is especially critical, as dying fungus from antifungal drugs can cause significant inflammation. When this inflammation affects the lungs, it can potentially prove fatal, making close monitoring essential during initial treatment.

Response to treatment should be monitored through repeat antigen testing, radiographic examinations, and clinical assessment. Even with appropriate duration of treatment, 20% to 25% of dogs will relapse after itraconazole therapy, making long-term follow-up monitoring important.

Cure and Recovery Criteria

A dog is considered cured of blastomycosis if specific criteria are met. The dog must demonstrate no clinical signs of the disease and must have received at least six months of treatment. Additionally, the dog must have at least two consecutive antigen readings of zero (0), indicating elimination of fungal antigens from the body. This two-in-a-row zero reading requirement ensures that the infection has truly been eradicated and not merely suppressed.

After achieving cure status, dogs should continue with check-ups every few months to ensure antigen levels remain at zero and disease has not recurred. This ongoing monitoring is particularly important given the potential for relapse months or years after initial treatment completion.

Prognosis

The prognosis for dogs with blastomycosis varies depending on the severity of infection, organ systems involved, and how quickly treatment is initiated. About 70% to 80% of dogs with blastomycosis respond completely to treatment with itraconazole, amphotericin B, or a combination of these drugs. However, treatment is a long-term commitment requiring dedication and financial investment from pet owners.

In severe cases, approximately 50% of severely affected dogs may die during the first week of treatment, despite appropriate medical intervention. The severity of disease at presentation significantly influences survival rates. Dogs presenting with severe respiratory distress, hypoxemia, or disseminated disease have a more guarded prognosis than those with milder, localized infections.

If appropriate treatment is started early, most dogs can be cured. However, long-term and potentially expensive treatment is often required. Dogs that survive the acute phase of illness and complete appropriate antifungal therapy have reasonable chances of recovery, though owners must understand the commitment involved and the possibility of recurrence.

Prevention and Risk Management

While no vaccine is currently available to prevent blastomycosis, risk can be minimized through environmental awareness. Dogs living in or traveling to endemic areas should have limited exposure to soil and organic debris, particularly in areas near water sources where the fungus is more likely to be present. Avoiding areas with known blastomycosis activity and keeping dogs indoors when possible can reduce exposure risk.

Early recognition of symptoms and prompt veterinary consultation are crucial for optimal outcomes. Any dog presenting with persistent cough, respiratory distress, unexplained weight loss, fever, or skin lesions should be evaluated by a veterinarian, particularly if the dog lives in or has traveled to endemic regions.

Frequently Asked Questions

Q: Can blastomycosis be transmitted from dog to dog?

A: No, blastomycosis cannot be directly transmitted from dog to dog. Dogs contract the infection by inhaling fungal spores from contaminated soil and organic matter in the environment, not through contact with other infected animals.

Q: Is blastomycosis contagious to humans?

A: Blastomycosis cannot be transmitted from dogs to humans. However, humans can contract blastomycosis through the same environmental exposure to contaminated soil and organic debris. The disease is not communicable between animals or from animals to people.

Q: How long does treatment for blastomycosis typically take?

A: Treatment usually takes at least four to six months, with many dogs requiring even longer therapy. Some dogs may need to continue treatment for up to a year or longer. Treatment must continue until active disease is not apparent and antigen levels are eliminated from the body.

Q: What is the cost of treating blastomycosis in dogs?

A: Treatment can be expensive, involving diagnostic tests, medications, and potentially hospitalization. Costs vary depending on the severity of disease and duration of treatment required. Pet owners should discuss financial considerations and payment options with their veterinarian.

Q: Can a dog relapse after successful treatment of blastomycosis?

A: Yes, relapse is possible. Even after successful treatment and achieving cure status with two consecutive zero antigen readings, approximately 20% of treated dogs may experience recurrence of disease months or years later. This is why continued monitoring through periodic check-ups is recommended.

Q: What should I do if my dog has been exposed to blastomycosis?

A: If your dog has been in an area where blastomycosis is known to occur, monitor for symptoms including cough, fever, lethargy, weight loss, and respiratory distress. Early recognition and veterinary evaluation are crucial. Do not delay seeking medical attention if your dog develops any concerning symptoms.

Similar Articles

Breathing Challenges in Flat-Faced Dogs

Diabetes in Dogs Guide

Nighttime Safety for Outdoor Cats

Managing Resource Guarding in Dogs

Cat Kneading Explained

Adding a Second Dog: Key Decisions

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to fluffyaffair,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete